| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹14,704 | -1.97% | |
| 6 months | ₹30,000 | ₹26,748 | -10.84% | |
| 1 year | ₹60,000 | ₹50,797 | -15.34% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Bharti Airtel Ltd | Technology | Equity | 15.52% |
| Infosys Ltd | Technology | Equity | 12.02% |
| Tata Consultancy Services Ltd | Technology | Equity | 9.73% |
| HCL Technologies Ltd | Technology | Equity | 7.10% |
| Mphasis Ltd | Technology | Equity | 5.41% |
| Tech Mahindra Ltd | Technology | Equity | 5.01% |
| Coforge Ltd | Technology | Equity | 4.31% |
| Info Edge (India) Ltd | Technology | Equity | 3.89% |
| HEXAWARE TECHNOLOGIES LIMITED EQ NEW FV RS.2/- | Technology | Equity | 3.83% |
| Firstsource Solutions Ltd | Industrials | Equity | 3.74% |
| Zomato Ltd | Technology | Equity | 3.60% |
| Zensar Technologies Ltd | Technology | Equity | 3.37% |
| Sonata Software Ltd | Technology | Equity | 2.83% |
| Amagi Media Labs Ltd. | Technology | Equity | 2.79% |
| Sagility India Ltd. | Industrials | Equity | 2.48% |
| eClerx Services Ltd | Technology | Equity | 2.27% |
| Repo | Unspecified | Repo | 2.19% |
| Tata Communications Ltd | Technology | Equity | 1.81% |
| Indus Towers Ltd | Technology | Equity | 1.49% |
| Brainbees Solutions Ltd. | Consumer Discretionary | Equity | 1.37% |
| Bharti Hexacom Ltd. | Technology | Equity | 1.25% |
| PB Fintech Ltd | Financial | Equity | 1.17% |
| Persistent Systems Ltd | Technology | Equity | 0.94% |
| Redington Ltd | Technology | Equity | 0.67% |
| Wipro Ltd | Technology | Equity | 0.67% |
| Unicommerce ESolutions Ltd. | Technology | Equity | 0.49% |
| PVR Ltd | Consumer Discretionary | Equity | 0.32% |
| Cyient Ltd | Technology | Equity | 0.08% |
| Net Payables | Unspecified | Net Payables | -0.35% |
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | -0.8% | -18.2% | -19.7% | +11.9% |
| Category average (Equity Sectoral) | -- | -- | -8.4% | -- |
| Rank (Equity Sectoral) | 10 | 9 | 10 | -- |